Ownership & Insider Lab

Look up a company to review current SEC-traceable insider positions, exact reporting-owner relationships across other published companies, a dated chronology of the published ownership evidence, and recent supported insider transactions where transaction history is separately available.
Coverage follows the existing reviewed company dataset and fails closed when a ticker is not currently supported.

GILEAD SCIENCES, INC. (GILD)

Nasdaq · SEC CIK 0000882095

$87.76MCovered current disclosed holdings
1Covered reporting owners
1Covered direct positions
1Source ownership filings

This is the supported SEC-traceable subset, not total insider ownership or personal wealth. Values reflect the current disclosed positions Grizzly Bulls can resolve and value. Latest source filing: Sep 11, 2026 · values through Sep 25, 2026.

Covered reporting owners

Filter the reporting-owner snapshot by holder, role, or security. Position values are shown only where the current reviewed data supports them.

1 shown
HolderRolePositionCurrent valueLatest filing
Daniel Patrick O'DayResearch disclosed relationshipsChairman & CEO · Director581,683 sharesCommon Stock, par value, $0.001 per share$87.76MSep 11, 2026

Reporting-owner research graph

These relationships are joined only when the same single SEC reporting-owner CIK appears unambiguously across the publication-authorized company ownership universe. Name similarity is never used to create a relationship.

This graph is bounded to the company ownership relationships currently published by Grizzly Bulls. It is not a complete employment, board, ownership, portfolio, or wealth history, and a missing relationship does not establish that none exists.

SEC transaction evidence ledger

Each row preserves the reviewed SEC transaction evidence, including the effective-date basis, amendment state, reported post-transaction position when present, and a separately published current covered owner/security position when one can be matched uniquely. Reported price is shown when present. The lab does not calculate gross proceeds, reconstruct balances between filings, or treat historical transactions as current wealth.

10 shown
Effective dateHolderActionSecurityUnitsReported priceReported position after transactionCurrent covered positionFiling
Sep 10, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsDispositionSEC code FCommon Stock, par value, $0.001 per share4,230 shares$144.81581,683 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Sep 11, 2026
Sep 10, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsAcquisitionSEC code MCommon Stock, par value, $0.001 per share8,780 sharesNot reported585,913 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Sep 11, 2026
Sep 1, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsSaleSEC code SCommon Stock, par value, $0.001 per share5,408 shares$149.3817577,133 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Sep 2, 2026
Sep 1, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsSaleSEC code SCommon Stock, par value, $0.001 per share7,992 shares$148.3636582,541 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Sep 2, 2026
Sep 1, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsSaleSEC code SCommon Stock, par value, $0.001 per share1,600 shares$147.5087590,533 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Sep 2, 2026
Aug 3, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsSaleSEC code SCommon Stock, par value, $0.001 per share600 shares$131.3433592,133 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Aug 4, 2026
Aug 3, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsSaleSEC code SCommon Stock, par value, $0.001 per share7,700 shares$130.8022592,733 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Aug 4, 2026
Aug 3, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsSaleSEC code SCommon Stock, par value, $0.001 per share6,700 shares$129.6583600,433 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Aug 4, 2026
Jul 1, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsSaleSEC code SCommon Stock, par value, $0.001 per share3,100 shares$127.075607,133 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Jul 2, 2026
Jul 1, 2026Transaction dateDaniel Patrick O'DayResearch disclosed relationshipsSaleSEC code SCommon Stock, par value, $0.001 per share11,900 shares$126.0897610,233 shares581,683 sharesOwner coverage latest filing Sep 11, 20264Filed Jul 2, 2026

A reported post-transaction position is the balance stated in that historical transaction filing. A current covered position is a separate latest owner/security observation and may reflect later filings or activity. They are shown side by side as evidence points, not as a reconstructed continuous ledger.

Published 10 of 10 source candidates under the current reviewed security-resolution rules.

Covered securities

SecurityInstrument familyCovered positionsCovered value
Common Stock, par value, $0.001 per shareordinary-share1$87.76M

Coverage and interpretation

Current holdings: direct positions that the reviewed ownership data can trace to an exact reporting owner, legal security, and current-basis quantity.

Current value: the existing published company-position valuation. This lab does not recalculate security values or infer missing positions.

Transaction evidence: historical flow observations with filing provenance. Reported post-transaction balances and current covered positions are separate evidence points; the lab does not interpolate ownership between them.

Reporting-owner graph: exact reporting-owner CIK relationships across the published company universe. It does not merge people by name or create a complete personal history.

Not included here: a claim of total insider ownership, total personal wealth, institutional 13F ownership, a transaction-value estimate, an insider sentiment score, or an investment recommendation.

Published ownership evidence chronology

This sequence orders only the ownership evidence already published by Grizzly Bulls for the exact reporting-owner relationships above. Transaction rows are ordered by filing date while preserving the separate economic effective date and its basis. Current covered snapshots remain separate latest observations.

The chronology does not interpolate ownership between entries, infer missing activity, pair an amended filing with an assumed parent, infer amendment supersession, or treat a current covered snapshot as proof of continuous ownership.

Daniel Patrick O'Day

SEC reporting-owner CIK 0001638643 · 1 published relationship company

SEC owner filings
Evidence dateCompanyObservationSecurity / positionSource
Sep 11, 2026Latest represented filing dateGILEAD SCIENCES, INC. (GILD)NasdaqCurrent covered snapshotChairman & CEO · DirectorValuation observation Sep 25, 2026Common Stock, par value, $0.001 per share: 581,683 sharesCurrent covered company value: $87.76MPublished current ownership snapshotForms represented: 4Owner filingsIssuer filings
Sep 11, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqAcquisitionSEC code MEffective Sep 10, 2026 · transaction dateReported units 8,780 shares · reported price not providedCommon Stock, par value, $0.001 per shareReported position after transaction: 585,913 shares4 filing0001638643-26-000033
Sep 11, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqDispositionSEC code FEffective Sep 10, 2026 · transaction dateReported units 4,230 shares · reported price 144.81Common Stock, par value, $0.001 per shareReported position after transaction: 581,683 shares4 filing0001638643-26-000033
Sep 2, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqSaleSEC code SEffective Sep 1, 2026 · transaction dateReported units 1,600 shares · reported price 147.5087Common Stock, par value, $0.001 per shareReported position after transaction: 590,533 shares4 filing0001638643-26-000031
Sep 2, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqSaleSEC code SEffective Sep 1, 2026 · transaction dateReported units 7,992 shares · reported price 148.3636Common Stock, par value, $0.001 per shareReported position after transaction: 582,541 shares4 filing0001638643-26-000031
Sep 2, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqSaleSEC code SEffective Sep 1, 2026 · transaction dateReported units 5,408 shares · reported price 149.3817Common Stock, par value, $0.001 per shareReported position after transaction: 577,133 shares4 filing0001638643-26-000031
Aug 4, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqSaleSEC code SEffective Aug 3, 2026 · transaction dateReported units 6,700 shares · reported price 129.6583Common Stock, par value, $0.001 per shareReported position after transaction: 600,433 shares4 filing0001638643-26-000028
Aug 4, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqSaleSEC code SEffective Aug 3, 2026 · transaction dateReported units 7,700 shares · reported price 130.8022Common Stock, par value, $0.001 per shareReported position after transaction: 592,733 shares4 filing0001638643-26-000028
Aug 4, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqSaleSEC code SEffective Aug 3, 2026 · transaction dateReported units 600 shares · reported price 131.3433Common Stock, par value, $0.001 per shareReported position after transaction: 592,133 shares4 filing0001638643-26-000028
Jul 2, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqSaleSEC code SEffective Jul 1, 2026 · transaction dateReported units 11,900 shares · reported price 126.0897Common Stock, par value, $0.001 per shareReported position after transaction: 610,233 shares4 filing0001638643-26-000026
Jul 2, 2026Filed dateGILEAD SCIENCES, INC. (GILD)NasdaqSaleSEC code SEffective Jul 1, 2026 · transaction dateReported units 3,100 shares · reported price 127.075Common Stock, par value, $0.001 per shareReported position after transaction: 607,133 shares4 filing0001638643-26-000026

Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 10 published transaction rows for this exact reporting-owner CIK appear in the chronology.

Continue this ownership research

These handoffs preserve the exact company identities already represented in the reporting-owner graph. My Stocks keeps a listed company in your existing research lists. Research Inbox is a separate company-change update workflow.

Saving a company to My Stocks never enables updates, and opening Research Inbox never subscribes you automatically. Each update remains an explicit company-level opt-in under the existing Research Inbox consent flow.

CompanyReporting-owner contextPublished evidenceContinue research
GILEAD SCIENCES, INC. (GILD)Nasdaq · Current company11Published chronology observationsLatest represented evidence Sep 11, 2026

These are company-level continuation paths, not reporting-owner subscriptions. Saving or watching one company does not automatically save or watch the other companies connected to the same reporting owner, and it does not create an owner-level alert.